Text Size
32 studies found for:    hemochromatosis

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
21 Completed Study With Deferiprone and/or Desferrioxamine in Iron Overloaded Patients
Condition: Hemochromatosis
Interventions: Drug: Deferiprone (L1);   Drug: Desferrioxamine
22 Recruiting Evaluation of Patients With Liver Disease
Conditions: Biliary Liver Cirrhosis,;   Hemochromatosis;   Hepatitis;   Hepatolenticular Degeneration;   Liver Disease
Intervention:
23 Unknown † Research Network for Neonatal Diseases Induced by Tissular Fetomaternal Alloimmunization
Conditions: Glomerulonephritis, Membranous;   Neonatal Diseases and Abnormalities;   Hemochromatosis
Intervention:
24 Terminated
Has Results 		Stroke With Transfusions Changing to Hydroxyurea
Conditions: Hemochromatosis;   Cerebrovascular Accident;   Anemia, Sickle Cell;   Hematologic Diseases
Interventions: Procedure: Red Cell Transfusions;   Procedure: Iron Chelation;   Drug: Hydroxyurea;   Procedure: Phlebotomy
25 Unknown † Clinical Importance of Treating Iron Overload in Sickle Cell Disease
Conditions: Anemia, Sickle Cell;   Transfusion Hemochromatosis
Intervention: Drug: deferasirox
26 Recruiting Mi-iron - Moderately Increased Iron - is Reducing Iron Overload Necessary?
Condition: Hereditary Haemochromatosis
Interventions: Procedure: Erythrocytapheresis;   Procedure: Plasmapheresis
27 Completed Pilot Study for Patients With Poor Response to Deferasirox
Conditions: Transfusion-dependent Hemachromatosis;   Thalassemia Major;   Sickle Cell Disease
Interventions: Drug: Deferoxamine;   Drug: Deferasirox;   Radiation: HIDA
28 Completed Iron Overload in Stem Cell Transplant Recipients
Condition: Iron Overload
Intervention:
29 Recruiting Massive Iron Deposit Assessment
Conditions: Iron Overload;   Excessive Body Iron Burden
Interventions: Device: R2*-UTE;   Device: R2*-GRE;   Procedure: Liver biopsy
30 Completed Risk Factors of Porphyria Cutanea Tarda (PCT)
Condition: Porphyria Cutanea Tarda
Intervention:
31 Completed Screening of Hepatocellular Carcinoma in Patients With Compensated Cirrhosis
Condition: Compensated Cirrhosis
Intervention: Procedure: Ultrasonographic screening
32 Completed Efficacy Study of the Use of Sequential DFP-DFO Versus DFP
Conditions: Beta-Thalassemia;   Thalassemia Major
Interventions: Drug: Deferiprone (DFP) and Deferoxamine (DFO);   Drug: Deferiprone (DFP)
To Top

Show previous page of results Previous Page (1-20) Studies Shown (21-32) Next Page
† Indicates status has not been verified in more than two years